MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Addition contact with 10 Hz stimulation in the STN may improve stimulation-induced cognitive disturbances

    A. Boogers, M. Cohn, M. Bernstein, A. Fasano (Toronto, Canada)

    Objective: This case report demonstrates improvement of cognition by adding low-frequency stimulation in the ventral subthalamic nucleus (STN). Background: Deep brain stimulation (DBS) targeting the…
  • 2023 International Congress

    Case Study: Pitfalls of Commercial Genetic Testing for Huntington’s Disease

    L. Fanty, J. Bravo, S. Corrigan, M. Maczis, L. Kugelmann, A. Wagle Shukla, M. Farrer, N. Mcfarland (Gainesville, USA)

    Objective: We present a family with initial false negative commercial testing for Huntington Disease (HD) and subsequent whole genome sequencing (WGS) that revealed an expanded…
  • 2023 International Congress

    Subjective cognitive decline and Frailty in an Asian cohort of patients with Parkinson’s Disease

    P. Venugopalan Menon, K. Gai Fui, E. Elda Kamaruddin, L. Sun, CH. Tan, P. Chong, S. Kumar Seetharaman (Singapore, Singapore)

    Objective: To assess the prevalence of subjective cognitive decline (SCD) and to look for its association with frailty in an Asian cohort of patients with…
  • 2023 International Congress

    Eye tracking paradigm to identify disease-specific behavioral biomarkers in neurodegeneration

    M. Habibi, B. Coe, D. Brien, H. Riek, A. Janzen, W. Oertel, D. Munoz (Marburg, Germany)

    Objective: Rapid-eye movement (REM) sleep behavior disorder (RBD) has been identified as the most specific and common prodromal stages of α-synucleinopathies (αSYN) such as Parkinson's…
  • 2023 International Congress

    Burden and management of tardive dyskinesia (TD): a cross-sectional international survey study to assess the perceptions and experiences of patients with TD

    R. Ribalov, A. Yaari, A. Peyser Levin, A. Yang, D. Horchi, E. Berjonneau, P. Le Calvé, M. Tian, S. Reshef, S. Reed (Tel-Aviv-Yafo, Israel)

    Objective: To assess patient perceptions of and experiences with TD and its impact on their daily functioning and quality of life (QoL). Background: There is…
  • 2023 International Congress

    Efficacy of perampanel in paroxysmal kinesigenic dyskinesia

    Z. Li, X. Huang, L. Cao (Shanghai, China)

    Objective: To explore the efficacy and safety of perampanel in the treatment of paroxysmal kinesigenic dyskinesia (PKD) Background: Perampanel is a new type of antiepileptic…
  • 2023 International Congress

    Individual-specific brain functional connectivity mapping of therapeutic response in task-specific focal dystonia

    E. Gordon, K. Matthews, A. Meyer, S. Norris (St. Louis, USA)

    Objective: Determine therapeutic effects of botulinum toxin on functional connectivity in individuals with task-specific dystonia. Background: Isolated task-specific dystonia occurs during specific activities, but not…
  • 2023 International Congress

    Double trouble: dystonic tremor due to FXTAS in a SCA1 family

    P. Santurelli, G. Bonato, R. Polli, A. Murgia, M. Carecchio (Padova, Italy)

    Objective: To describe a patient belonging to a SCA1 family, who presented with action tremor and dysmetria but with a different genetic etiology. Background: Spino-Cerebellar…
  • 2023 International Congress

    An European-Canadian multinational evaluation of access to care in Parkinson disease: a patient perspective

    M. van Munster, E. Crighton, A. Sánchez-Ferro, J. Ferreira, R. Bouça, E. Ruzicka, D. Pedrosa, D. Grimes, T. Mestre (Marburg, Germany)

    Objective: To provide a multi-national perspective of people with Parkinson disease (PwPD) on access to healthcare and the impact of the COVID-19 pandemic on those…
  • 2023 International Congress

    Long-term follow up of Deep Brain Stimulation in Pantothenate Kinase-Associated Neurodegeneration Syndrome: two case reports

    D. Damas, I. Carvalho, S. Caldeira, P. Monteiro, R. Pereira, I. Cunha, F. Moreira (Coimbra, Portugal)

    Objective: To present the long-term outcomes of deep brain stimulation in two cases of Pantothenate kinase-associated neurodegeneration (PKAN) syndrome. Background: PKAN syndrome is an autosomal-recessive…
  • « Previous Page
  • 1
  • …
  • 429
  • 430
  • 431
  • 432
  • 433
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley